{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "North Chicago",
      "state": "IL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78143",
      "recalling_firm": "AbbVie Inc.",
      "address_1": "1 N Waukegan Rd",
      "address_2": "N/A",
      "postal_code": "60064-1802",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "AZ",
      "recall_number": "D-0033-2018",
      "product_description": "AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone per pump actuation, 60 metered pump actuations, Rx Only, Marketed by:  AbbVie Inc., North Chicago, IL 60064 USA.  NDC: 0051-8462-33",
      "product_quantity": "520 pumps",
      "reason_for_recall": "Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.",
      "recall_initiation_date": "20170908",
      "center_classification_date": "20171025",
      "termination_date": "20180423",
      "report_date": "20171101",
      "code_info": "Lot: 91122, EXP. 01/2020"
    }
  ]
}